glp-1 dementia improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway Glucose-lowering therapies may reduce risk

Both are administered via a weekly injection and shown to produce meaningful weight loss when combined with lifestyle changes

For patients with significant injection anxiety, distraction techniques, topical numbing agents (after consultation with a healthcare provider), or ice application before injection may provide additional comfort

Zepbound, or tirzepatide in general, while operating under the same mechanism as other GLP-1 drugs, may exhibit subtle differences in its onset of effects due to its formulation

While it's designed for long-term use, it's always best to consult a healthcare professional to ensure it's the right choice for your health and weight management goals

However, both medications suppress appetite and may affect cardiovascular function, requiring careful medical supervision and monitoring when used together

How to Cite Canadian Diabetes & Endocrinology Today , 3 (1), 1722.